Recurrent PET FDG Uptake after Sequential Chemotherapy and Radiation Therapy for DLBCL of the Tibia: A Case Report and Review of the Literature

about

Recurrent PET FDG Uptake after Sequential Chemotherapy and Radiation Therapy for DLBCL of the Tibia: A Case Report and Review of the Literature

Item

http://www.wikidata.org/entity/Q35952479

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Recurrent PET FDG Uptake after ...... t and Review of the Literature

@ast

Recurrent PET FDG Uptake after ...... t and Review of the Literature

@en

type

Item

label

Recurrent PET FDG Uptake after ...... t and Review of the Literature

@ast

Recurrent PET FDG Uptake after ...... t and Review of the Literature

@en

prefLabel

Recurrent PET FDG Uptake after ...... t and Review of the Literature

@ast

Recurrent PET FDG Uptake after ...... t and Review of the Literature

@en

P1476

Recurrent PET FDG Uptake after ...... t and Review of the Literature

@en

P2093

David B Turton

http://www.w3.org/2001/XMLSchema#string

Edward F Miles

http://www.w3.org/2001/XMLSchema#string

Luke Balsamo

http://www.w3.org/2001/XMLSchema#string

William Graf

http://www.w3.org/2001/XMLSchema#string

P2860

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

Primary bone lymphoma--treatment and outcome.

NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas.

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

Limited chemotherapy and shrinking field radiotherapy for Osteolymphoma (primary bone lymphoma): results from the trans-Tasman Radiation Oncology Group 99.04 and Australasian Leukaemia and Lymphoma Group LY02 prospective trial.

Primary lymphoma of bone in adult patients.

Treatment of stage IE primary lymphoma of bone.

Stage IE primary non-Hodgkin's lymphoma of bone.

Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients.

P304

163472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1155/2011/163472

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224980405

http://www.w3.org/2001/XMLSchema#string

P698

22606440

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

3350025

http://www.w3.org/2001/XMLSchema#string